Genes (Sep 2022)

Identification of Two Novel <i>EPOR</i> Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review

  • Laura Lo Riso,
  • Gardenia Vargas-Parra,
  • Gemma Navarro,
  • Leonor Arenillas,
  • Lierni Fernández-Ibarrondo,
  • Beatriz Robredo,
  • Carmen Ballester,
  • Bernardo López,
  • Albert Perez-Montaña,
  • Antonia Sampol,
  • Lourdes Florensa,
  • Carles Besses,
  • María Antonia Duran,
  • Beatriz Bellosillo

DOI
https://doi.org/10.3390/genes13101686
Journal volume & issue
Vol. 13, no. 10
p. 1686

Abstract

Read online

Primary familial and congenital polycythemia is a rare disease characterized by an increase in red cell mass that may be due to pathogenic variants in the EPO receptor (EPOR) gene. To date, 33 genetic variants have been reported to be associated. We analyzed the presence of EPOR variants in two patients with polycythemia in whom JAK2 pathogenic variants had been previously discarded. Molecular analysis of the EPOR gene was performed by Sanger sequencing of the coding regions and exon/intron boundaries of exon 8. We performed in vitro culture of erythroid progenitor cells. Segregation studies were done whenever possible. The two patients studied showed hypersensitivity to EPO in in vitro cultures. Analysis of the EPOR gene unveiled two novel pathogenic variants. Genetic testing of asymptomatic relatives could guarantee surveillance and proper management.

Keywords